Realta Investment Advisors Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Realta Investment Advisors increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,200 shares of the medical equipment provider’s stock after buying an additional 81 shares during the quarter. Realta Investment Advisors’ holdings in Intuitive Surgical were worth $1,178,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. China Universal Asset Management Co. Ltd. boosted its position in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Finally, Consolidated Planning Corp grew its stake in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,940 shares of company stock worth $3,333,485. 0.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on ISRG shares. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Finally, Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 0.4 %

ISRG stock opened at $588.50 on Friday. The stock has a market cap of $209.61 billion, a PE ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. The firm’s 50-day simple moving average is $554.03 and its 200 day simple moving average is $513.12. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.